Chelation therapy may help reduce one's risk for developing cardiovascular conditions.

 

Did you know that heart disease is the leading cause of death in America? Nearly 610,000 people in the U.S. die from this condition annually, according to the Centers for Disease Control and Prevention. Cardiovascular disease occurs when plaque builds up in the arteries, causing them to narrow and disrupt the flow of blood. Some of the most common risk factors include smoking, following a poor diet and lack of exercise, or having high cholesterol, high blood pressure and diabetes.

Removing prior unhealthy habits and working to improve your overall health is a positive step in the right direction to decrease your risk for cardiovascular disease or cope with the condition. However, there may be another resolution: chelation therapy.

What is chelation therapy?

According to the National Center for Complementary and Integrative Health, chelation therapy is defined as a chemical process that occurs when a substance binds to molecules. Most commonly, chelation therapy is used to rid the body of excess toxins and metals.

How does it impact cardiovascular disease?

Chelation therapy has also been considered a complementary treatment for those living with heart disease, where doctors administer a man-made amino acid called disodium EDTA intravenously to fuel the body with high doses of antioxidants, vitamins and minerals.

“The TACT was created to determine the impact of chelation therapy on cardiovascular disease.”

To test if chelation therapy can indeed be useful for those with cardiovascular disease, the NCCIH and the National Heart, Lung and Blood Institute worked together to sponsor a study – the Trial to Assess Chelation Therapy (TACT) – to determine the impact chelation therapy could have on heart attack patients.

The placebo-controlled, double-blind study was made up of 1,708 participants over the age of 50 who had a heart attack in the past. Individuals received either the chelation therapy or solution via 40 intravenous infusion over 28 months.

By the end of the TACT study – and after a 5-year followup – researchers concluded that the infusion of disodium EDTA reduced heart attack, stroke, hospitalization for angina and coronary revascularization risk by 18 percent.

Visit the Longevity Centres
After various tests and research, the specialists at the Longevity & Stem Cell Centre of Houston have devised an IV chelation therapy method of disodium EDTA to target toxins in the body. We believe that this method of restorative medicine can be used to help combat heart disease, reduce stroke risk and prevent other conditions that disrupt the health aging process.

To learn more about how the Longevity Centres can help you live your healthiest and most fulfilling life, contact us directly today.